Aroa Biosurgery Ltd
ASX:ARX
Cash Flow Statement
Cash Flow Statement
Aroa Biosurgery Ltd
| Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||
| Stock-Based Compensation |
2
|
0
|
3
|
22
|
3
|
(15)
|
3
|
3
|
2
|
2
|
|
| Cash Taxes Paid |
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(0)
|
|
| Cash Interest Paid |
(1)
|
(2)
|
(1)
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
|
| Change in Working Capital |
0
|
0
|
0
|
0
|
1
|
2
|
2
|
2
|
2
|
1
|
|
| Cash from Operating Activities |
(5)
N/A
|
(8)
-56%
|
(12)
-48%
|
(10)
+10%
|
(4)
+64%
|
(6)
-72%
|
(7)
-14%
|
(5)
+33%
|
(3)
+48%
|
6
N/A
|
|
| Investing Cash Flow | |||||||||||
| Capital Expenditures |
(2)
|
(3)
|
(5)
|
(5)
|
(8)
|
(8)
|
(7)
|
(6)
|
(4)
|
(3)
|
|
| Other Items |
(20)
|
0
|
(30)
|
(18)
|
15
|
8
|
17
|
22
|
4
|
(5)
|
|
| Cash from Investing Activities |
(22)
N/A
|
(3)
+86%
|
(35)
-1 070%
|
(23)
+33%
|
7
N/A
|
(0)
N/A
|
10
N/A
|
16
+58%
|
0
-98%
|
(8)
N/A
|
|
| Financing Cash Flow | |||||||||||
| Net Issuance of Common Stock |
35
|
50
|
50
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
(13)
|
(10)
|
(10)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Other |
15
|
(3)
|
(3)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Cash from Financing Activities |
37
N/A
|
37
+1%
|
38
+1%
|
(1)
N/A
|
(1)
+13%
|
(1)
-51%
|
(1)
-36%
|
(1)
-16%
|
(1)
-23%
|
(2)
-12%
|
|
| Change in Cash | |||||||||||
| Effect of Foreign Exchange Rates |
1
|
0
|
(0)
|
1
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
|
| Net Change in Cash |
12
N/A
|
27
+131%
|
(9)
N/A
|
(33)
-261%
|
3
N/A
|
(8)
N/A
|
2
N/A
|
10
+386%
|
(4)
N/A
|
(3)
+11%
|
|
| Free Cash Flow | |||||||||||
| Free Cash Flow |
(7)
N/A
|
(11)
-66%
|
(16)
-52%
|
(15)
+6%
|
(11)
+26%
|
(15)
-31%
|
(14)
+4%
|
(11)
+24%
|
(6)
+43%
|
3
N/A
|
|